PMC:7402624 / 19415-19646 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T134","span":{"begin":150,"end":153},"obj":"Body_part"},{"id":"T135","span":{"begin":174,"end":179},"obj":"Body_part"}],"attributes":[{"id":"A134","pred":"fma_id","subj":"T134","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A135","pred":"fma_id","subj":"T135","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"equencies were also higher in RD compared to HD (Fig. 3B), perhaps reflecting residual COVID-19 responses in that group. Frequencies of KI67+ or CD38+HLA-DR+ non-naïve CD4 T cells were increased in COVID-19 patients (Fig. 3, C and "}

{"project":"LitCovid-PubTator","denotations":[{"id":"686","span":{"begin":145,"end":149},"obj":"Gene"},{"id":"687","span":{"begin":168,"end":171},"obj":"Gene"},{"id":"716","span":{"begin":207,"end":215},"obj":"Species"},{"id":"732","span":{"begin":45,"end":47},"obj":"Disease"},{"id":"733","span":{"begin":87,"end":95},"obj":"Disease"},{"id":"734","span":{"begin":198,"end":206},"obj":"Disease"}],"attributes":[{"id":"A686","pred":"tao:has_database_id","subj":"686","obj":"Gene:952"},{"id":"A687","pred":"tao:has_database_id","subj":"687","obj":"Gene:920"},{"id":"A716","pred":"tao:has_database_id","subj":"716","obj":"Tax:9606"},{"id":"A732","pred":"tao:has_database_id","subj":"732","obj":"MESH:D006816"},{"id":"A733","pred":"tao:has_database_id","subj":"733","obj":"MESH:C000657245"},{"id":"A734","pred":"tao:has_database_id","subj":"734","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"equencies were also higher in RD compared to HD (Fig. 3B), perhaps reflecting residual COVID-19 responses in that group. Frequencies of KI67+ or CD38+HLA-DR+ non-naïve CD4 T cells were increased in COVID-19 patients (Fig. 3, C and "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T144","span":{"begin":30,"end":32},"obj":"Disease"},{"id":"T145","span":{"begin":45,"end":47},"obj":"Disease"},{"id":"T146","span":{"begin":87,"end":95},"obj":"Disease"},{"id":"T147","span":{"begin":198,"end":206},"obj":"Disease"}],"attributes":[{"id":"A144","pred":"mondo_id","subj":"T144","obj":"http://purl.obolibrary.org/obo/MONDO_0009973"},{"id":"A145","pred":"mondo_id","subj":"T145","obj":"http://purl.obolibrary.org/obo/MONDO_0007739"},{"id":"A146","pred":"mondo_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A147","pred":"mondo_id","subj":"T147","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"equencies were also higher in RD compared to HD (Fig. 3B), perhaps reflecting residual COVID-19 responses in that group. Frequencies of KI67+ or CD38+HLA-DR+ non-naïve CD4 T cells were increased in COVID-19 patients (Fig. 3, C and "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T327","span":{"begin":30,"end":32},"obj":"http://purl.obolibrary.org/obo/CLO_0008770"},{"id":"T328","span":{"begin":145,"end":149},"obj":"http://purl.obolibrary.org/obo/PR_000001408"},{"id":"T329","span":{"begin":162,"end":179},"obj":"http://purl.obolibrary.org/obo/CL_0000895"}],"text":"equencies were also higher in RD compared to HD (Fig. 3B), perhaps reflecting residual COVID-19 responses in that group. Frequencies of KI67+ or CD38+HLA-DR+ non-naïve CD4 T cells were increased in COVID-19 patients (Fig. 3, C and "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T98","span":{"begin":30,"end":32},"obj":"Chemical"},{"id":"T99","span":{"begin":45,"end":47},"obj":"Chemical"},{"id":"T100","span":{"begin":114,"end":119},"obj":"Chemical"},{"id":"T101","span":{"begin":154,"end":156},"obj":"Chemical"}],"attributes":[{"id":"A98","pred":"chebi_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/CHEBI_73812"},{"id":"A99","pred":"chebi_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/CHEBI_73925"},{"id":"A100","pred":"chebi_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A101","pred":"chebi_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"}],"text":"equencies were also higher in RD compared to HD (Fig. 3B), perhaps reflecting residual COVID-19 responses in that group. Frequencies of KI67+ or CD38+HLA-DR+ non-naïve CD4 T cells were increased in COVID-19 patients (Fig. 3, C and "}